公司资料
Onconova Therapeutics 股价、新闻与催化剂
- 股票代码:
- ONTX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
16.35 USD (-7.06%)
收盘价
最后更新: 2026年8月24日
—
市值
股价为何变动
As of Aug 24, 2026, ONTX closed down 7.06% at $16.35. No new same-company headline was identified in the current news window.
公司概览
业务概览
Onconova Therapeutics is a development-stage oncology company focused on targeted cancer therapies and precision approaches to hard-to-treat malignancies. Its investment case comes from the possibility that a small set of programs can generate meaningful clinical and strategic value.
所在地与行业分类
Onconova is headquartered in the United States and listed on NASDAQ, with a small-cap oncology biotech profile. It sits in the classic development-stage cancer-therapeutics category.
商业模式特征
The business depends on clinical progress, regulatory optionality, and capital preservation. Investors usually focus on proof-of-concept data, pipeline prioritization, and whether the company can extend its runway long enough to create value.
生物医药行业定位
Onconova occupies a highly volatile oncology niche within biotech. Like many small cancer-drug developers, its stock can reprice sharply around data, financing, or partnership news.
未来催化剂
- Onconova is another legacy closeout name, with catalysts limited to any strategic or asset-disposition update. The market is mainly waiting for what value remains.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。